Primer combination and its application and method for digital detection of Clonorchis sinensis nucleic acid
Through isothermal amplification technology, CRISPR/Cas12a system and functional magnetic bead sensor, a Chinese trenchymal detection platform without large instruments is built, solving the problems of low sensitivity and time-consuming of existing detection methods and achieving rapid , accurate and low-cost testing effects, suitable for epidemic monitoring and screening of grassroots health institutions and veterinary departments.
Patent Information
- Application Number
- CN202410995722.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-07-24
AI Technical Summary
The existing detection methods of cynomolgus cynomolgus have problems such as low sensitivity, long time-consuming and difficult to screen on a large scale, and require professionals to identify insect eggs, resulting in insufficient detection efficiency and accuracy.
Using isothermal amplification technology, CRISPR/Cas12a system and functional magnetic bead sensors, a detection platform that does not require large-scale instrument assistance, isothermal amplification, and isothermal sensitivity is constructed. Through target gene screening, RPA isothermal amplification and CRISPR/ Cas12a recognition is combined with a blood glucose meter for digital detection.
It has achieved rapid, accurate and low-cost detection of Cystosacia , suitable for on-site instant detection , strong specificity and high sensitivity , suitable for epidemic monitoring and screening in grassroots health institutions and veterinary departments .
Smart Images

Figure CN118516476B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the fields of biology and chemistry, and in particular to a primer combination and an application and method thereof for digital detection of nucleic acid of Clonorchis sinensis. Background Art
[0002] Clonorchis sinensis is an important foodborne zoonotic parasite. It is reported that more than 200 million people worldwide are at risk of infection with Clonorchis sinensis. In addition, Clonorchiasis is closely related to diseases such as bile duct cancer and liver fibrosis. In 2009, the WHO classified Clonorchis sinensis as a Class I biological carcinogen.
[0003] At present, the "gold standard" for detecting Clonorchis sinensis is still to detect eggs in feces. This method is low-cost and can quantify the intensity of infection based on the number of eggs. However, this method also has defects. First, the sensitivity of the microscopic examination is relatively low. When the body is infected with low intensity, the amount of eggs discharged is small, and fecal microscopy is easy to miss, resulting in a "false negative" result; second, professional personnel are required to identify Clonorchis sinensis eggs. There are many types of intestinal parasites, and the eggs produced by some parasites are very similar. It is difficult for people without professional training to accurately distinguish them; finally, this method is time-consuming and difficult to apply to large-scale case screening.
[0004] Using specific genes to identify pathogens is a powerful scientific method. The mitochondria of eukaryotes have high copy numbers in cells, their sequences are conserved between species, and they are specific within species. In addition, because their functions play a very important role in life activities, they are ideal targets for studying parasite taxonomy and phylogenetics. Summary of the invention
[0005] In view of this, in order to solve the problems existing in the existing diagnostic technology of Clonorchis sinensis, the present invention uses isothermal amplification technology, CRISPR / Cas12a system and functionalized magnetic bead sensors to construct a new detection platform that does not require the assistance of large instruments, has low cost, good specificity and high sensitivity, and is suitable for on-site instant detection of Clonorchis sinensis.
[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0007] In a first aspect, the present invention provides the use of a target gene as a marker in any of the following items;
[0008] (I) Detection of Clonorchis sinensis;
[0009] (II) Use in the preparation of reagents or kits for detecting Clonorchis sinensis;
[0010] The target gene has:
[0011] (i) the nucleotide sequence shown in SEQ ID NO.1;
[0012] (ii) a nucleotide sequence that encodes the same protein as the nucleotide sequence shown in (i) but differs from the nucleotide sequence shown in (i) due to the degeneracy of the genetic code; or
[0013] (iii) a nucleotide sequence obtained by substituting, deleting or adding one or more nucleotide sequences to the nucleotide sequence shown in (i) or (ii), and having the same or similar functions as the nucleotide sequence shown in (i) or (ii); or
[0014] (iv) a nucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence homology to the nucleotide sequence of any one of (i) to (iii).
[0015] In a second aspect, the present invention further provides a primer combination, the primer combination comprising:
[0016] (I), the forward primer has the nucleotide sequence shown in SEQ ID NO.6; the reverse primer has the nucleotide sequence shown in SEQ ID NO.7; or
[0017] (II) a nucleotide sequence that encodes the same protein as the nucleotide sequence shown in (I) but is different from the nucleotide sequence shown in (I) due to the degeneracy of the genetic code; or
[0018] (III) a nucleotide sequence obtained by replacing, deleting or adding one or more nucleotide sequences to the nucleotide sequence shown in (I) or (II), and having the same or similar function as the nucleotide sequence shown in (I) or (II); or
[0019] (IV) A nucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence homology to any one of the nucleotide sequences of (I) to (III).
[0020] In a third aspect, the present invention further provides a detection composition, comprising one or more of gRNA, a fluorescent reporter group or ssDNA, and the primer combination provided by the present invention;
[0021] The gRNA has:
[0022] (A), the nucleotide sequence shown in SEQ ID NO. 8 or 9; or
[0023] (B), a nucleotide sequence that encodes the same protein as the nucleotide sequence shown in (A), but is different from the nucleotide sequence shown in (A) due to the degeneracy of the genetic code; or
[0024] (C) a nucleotide sequence obtained by replacing, deleting or adding one or more nucleotide sequences to the nucleotide sequence shown in (A) or (B), and a nucleotide sequence having the same or similar function as the nucleotide sequence shown in (A) or (B); or
[0025] (D) a nucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence homology to any one of (A) to (C);
[0026] The fluorescent reporter group has:
[0027] (a), the nucleotide sequence shown as TTAATAA; or
[0028] (b) a nucleotide sequence that encodes the same protein as the nucleotide sequence shown in (a) but is different from the nucleotide sequence shown in (A) due to the degeneracy of the genetic code; or
[0029] (c) a nucleotide sequence obtained by substituting, deleting or adding one or more nucleotide sequences to the nucleotide sequence shown in (a) or (b), and having the same or similar functions as the nucleotide sequence shown in (a) or (b); or
[0030] (d) a nucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence homology to the nucleotide sequence of any one of (a) to (c);
[0031] The ssDNA has:
[0032] (1) The nucleotide sequence shown in SEQ ID NO.10; or
[0033] (2) a nucleotide sequence that encodes the same protein as the nucleotide sequence shown in (1) but is different from the nucleotide sequence shown in (1) due to the degeneracy of the genetic code; or
[0034] (3) a nucleotide sequence obtained by replacing, deleting or adding one or more nucleotide sequences to the nucleotide sequence shown in (1) or (2), and having the same or similar functions as the nucleotide sequence shown in (1) or (2); or
[0035] (4) A nucleotide sequence having at least 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence homology to the nucleotide sequence of any one of (1) to (3).
[0036] In some specific embodiments of the present invention, the detection composition includes one or more of an RPA reaction system, a CRISPR / Cas12 fluorescence reaction system, or a blood glucose meter reaction system;
[0037] The RPA reaction system, based on 50 μL, includes:
[0038] The upstream primer (10 μM) 2.4 μL
[0039] The downstream primer (10 μM) 2.4 μL
[0040] Buffer 29.5μL
[0041] MgOAc (280 mM) 2.5 μL
[0042] Genomic DNA of the sample to be tested 1ng
[0043] Make up to 50 μL with water;
[0044] The CRISPR / Cas12 fluorescent reaction system is measured in 50 μL and includes:
[0045] RPA amplification product 5 μL
[0046] Cas12a protein 50nM
[0047] The gRNA 75nM
[0048] The fluorescent reporter group 100nM
[0049] Cas12a Buffer 5μL
[0050] Add dd H2O to make up to 50 μL;
[0051] The reaction system of the blood glucose meter is based on 50 μL and includes:
[0052] Functional magnetic beads 10 μL
[0053] Case12a protein 50 nM
[0054] The gRNA 75nM
[0055] RPA-product 5μL
[0056] Cas12a Buffer 5μL
[0057] Add dd H2O to 50 μL; react at 37°C for 30 min;
[0058] The functional magnetic beads include magnetic beads labeled with streptavidin, the ssDNA and sucrase.
[0059] In a fourth aspect, the present invention further provides the use of any one of the following in detecting Clonorchis sinensis or preparing a reagent or kit for detecting Clonorchis sinensis;
[0060] (I), the primer combination described; or
[0061] (II), the detection composition.
[0062] In some specific embodiments of the present invention, the reaction procedure of the CRISPR / Cas12 fluorescent reaction system is: using a multifunctional microplate reader to react at 37° C. for 30 minutes, and collecting the FAM fluorescence intensity once every 20 seconds.
[0063] In a fifth aspect, the present invention also provides a method for detecting the digitalization of Clonorchis sinensis nucleic acid for non-diagnostic purposes, characterized in that, based on the primer combination or the detection composition, a sample to be tested is taken, amplified by RPA isothermal amplification technology, the CRISPR / Cas12a system recognizes the target gene, trans-cuts the fluorescent reporter group 5'-FAM-Reporter-BHQ1-3', or cuts the ssDNA single strand on the functional magnetic beads to release sucrase; the functional magnetic beads are separated to obtain free sucrase, which catalyzes the substrate sucrose to produce glucose; the glucose concentration is measured to obtain the digital detection result of Clonorchis sinensis nucleic acid;
[0064] Preferably, the reaction degree of the RPA isothermal amplification technology is: constant temperature reaction at 39° C. for 20 min;
[0065] Preferably, the reaction procedure of the CRISPR / Cas12 system is: using a multifunctional microplate reader to react at 37° C. for 30 min, and collecting the FAM fluorescence intensity once every 20 s;
[0066] Preferably, the reaction procedure of the blood glucose meter is: constant temperature reaction at 50°C for 15 min.
[0067] In some specific embodiments of the present invention, the glucose concentration is specifically determined as follows: separate and remove the magnetic beads of the functional magnetic beads, take 10 μL of the reaction product and add it to 30 μL of 50 mM sucrose (0.1 M sodium acetate) solution, and react at 50°C for 15 min; take 5 μL of the product and read the value with a blood glucose meter test strip. If the result is positive, the blood glucose meter displays the reading; if the result is negative, the blood glucose meter displays a "LOW" mark.
[0068] In a sixth aspect, the present invention further provides a reagent or a kit, comprising any of the following:
[0069] (I), the primer combination described; or
[0070] (II), the detection composition.
[0071] In a seventh aspect, the present invention further provides a processor, wherein the processor is used to run a program, wherein the detection method is executed when the program is running.
[0072] In an eighth aspect, the present invention further provides an electronic device or apparatus, characterized in that the electronic device comprises: a memory and the processor;
[0073] Wherein, one or more computer programs are stored in the memory, and the one or more computer programs include instructions; when the instructions are executed by the processor, the electronic device executes the detection method;
[0074] The device includes one or more components, and the one or more components implement the detection method.
[0075] The present invention provides a method for digital detection of nucleic acid of Clonorchis sinensis based on RPA-CRISPR / Cas12a-blood glucose meter signal transduction, the method comprising the following steps: (1) screening of Clonorchis sinensis specific target genes; (2) isothermal amplification of target genes by recombinase polymerase; (3) recognition of target genes by CRISPR / Cas12a system, trans-cutting ssDNA of functional magnetic bead probes, and releasing sucrase; (4) separation of magnetic beads, free sucrase catalyzing substrate sucrose to generate glucose; (5) measuring glucose concentration by blood glucose meter to realize digital detection of nucleic acid. The present invention has strong specificity, high sensitivity, low cost, no need for expensive instrument assistance, easy reading of detection results, and has certain application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0076] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art are briefly introduced below.
[0077] Figure 1The comparison results of the whole mitochondrial genomes of six parasites (Clonorchis sinensis, Mesorchis orientalis, Opisthorchis civetus, Fasciola hepatica, Schistosoma japonicum and Anastomosoma anatum) are shown;
[0078] Figure 2 The results of PCR verification of the specificity of the primers CSmt F / CSmt R for Clonorchis sinensis; wherein, M is a DNA marker, 1 is Clonorchis sinensis, 2 is Mesorchis orientalis, 3 is Fasciola hepatica, 4 is Taenia asiatica, 5 is Taenia solium, 6 is Ancylostoma duodenale, 7 is Cryptosporidium, and 8 is a negative control;
[0079] Figure 3 Shows the results of gRNA screening of Clonorchis sinensis CRISPR / Cas12a system;
[0080] Figure 4 Shows the results of Case12a protein concentration screening in the CRISPR / Cas12a system of Clonorchis sinensis;
[0081] Figure 5 Shows the gRNA concentration screening results of the CRISPR / Cas12a system of Clonorchis sinensis;
[0082] Figure 6 The results of the specificity test of the RPA-CRISPR / Cas12a fluorescence system of Clonorchis sinensis are shown;
[0083] Figure 7 Shows the results of the sensitivity test of Clonorchis sinensis RPA-CRISPR / Cas12a fluorescence system;
[0084] Figure 8 The results of characterization of functional magnetic beads of Clonorchis sinensis RPA-CRISPR / Cas12a-blood glucose meter system are shown;
[0085] Fig. 9 Shows the sensitivity test of Clonorchis sinensis RPA-CRISPR / Cas12a-blood glucose meter system;
[0086] Fig.10 The detection effect of three pairs of primers designed based on the target gene region in Example 1 is shown. DETAILED DESCRIPTION
[0087] The present invention discloses primer combinations and their applications and methods for digital detection of nucleic acid of Clonorchis sinensis. Those skilled in the art can refer to the content of this article and appropriately improve the process parameters for implementation. It should be particularly noted that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The methods and applications of the present invention have been described through preferred embodiments, and relevant personnel can obviously modify or appropriately change and combine the methods and applications described herein without departing from the content, spirit and scope of the present invention to implement and apply the technology of the present invention.
[0088] In order to solve the problems existing in the existing diagnostic technology of Clonorchis sinensis, the present invention uses isothermal amplification technology, CRISPR / Cas12a system and functionalized magnetic bead sensors to construct a new detection platform that does not require the assistance of large instruments, has low cost, good specificity and high sensitivity, and is suitable for on-site instant detection of Clonorchis sinensis.
[0089] The present invention is achieved through the following technical solutions:
[0090] Step 1: 1) Obtain the mitochondrial genome sequences of six parasites, including Clonorchis sinensis, Mesorchis orientalis, Opisthorchis civetus, Fasciola hepatica, Schistosoma japonicum, and Anatidae from Genbank, use MEGA X software to compare and analyze the sequences, select the unique sequence of Clonorchis sinensis as the target gene, and use Primer 5 software to design amplification primers.
[0091] Step 2: The specific target gene sequence of Clonorchis sinensis obtained by screening is: 5'-ggataccaccatccattacaagttcctatcctaccctctcaaaacttttctgtccctccgagtatcaaccaacaccaagtcaccttccacataatacccctctcattaacatcctatctaccccgcaatcctacagcctacctgctgcctcttccagcgcctatatattactctccaaccttctttggatctcctctccctctctc-3' (SEQ ID No.1). The upstream primer CSmt F sequence is: 5'- ggataccaccatccattacaagttcc-3' (SEQ ID No.6), and the downstream primer CSmt R sequence is: 5'-gagagagggagaggagatccaaagaagg-3' (SEQ ID No.7).
[0092] Step 3: Design gRNA according to the target gene sequence, gRNA1: 5'-uaauuucuacuaaguguagauuacccaauauauaugaugugc-3' (SEQ ID No.8), gRNA2: 5'-uaauuucuacuaaguguagaucacauaauaccccucucauua-3' (SEQ ID No.9).
[0093] Step 4: Amplify the target gene sequence using RPA isothermal amplification technology, gRNA binds to Cas12a, specifically recognizes the amplified product, activates the trans-cleavage function, cuts the fluorescent reporter group 5'-FAM-Reporter-BHQ1-3', and the fluorescent reporter group sequence is TTAATAA (since less than 10 nucleotides cannot generate a sequence table, it is not numbered here), or cuts the ssDNA single strand on the functional magnetic beads to release sucrase. The composition of the functional magnetic beads includes streptavidin-labeled magnetic beads, ssDNA, and sucrase. The ssDNA is: 5'-SH-ssDNA-Biotin-3, and the ssDNA sequence is 5'-ttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt-3' (SEQ ID No.10).
[0094] Step 5: RPA reaction system 50μL: including upstream primer 2.4μL (10μM), downstream primer 2.4μL (10μM), Buffer 29.5μL, MgOAc 2.5μL (280mM), 1ng of genomic DNA of the sample to be tested, make up to 50μL with water, and react at 39℃ for 20min. CRISPR / Cas12 fluorescence reaction system is 50μL: including 5μL RPA amplification product, Cas12a protein 50nM, gRNA 75nM, fluorescent reporter group 100nM, Cas12a Buffer 5μL, dd H2O make up to 50μL; CRISPR / Cas12a reaction procedure is: use a multifunctional microplate reader to react at 37℃ for 30min, and collect FAM fluorescence intensity once every 20s.
[0095] Step 6: The reaction system of the blood glucose meter is 50μL: 10μL functional magnetic beads, 50nM Case12a protein, 75nM gRNA, 5μL RPA-product, 5μL Cas12a Buffer, and dd H2O to 50μL; react at 37℃ for 30 min.
[0096] Step 7: Use a magnetic stand to separate and remove the functional magnetic beads in step 6, take 10 μL of the reaction product and add it to 30 μL of 50 mM sucrose (0.1 M sodium acetate solution) solution, and react at 50 ℃ for 15 min. Take 5 μL of the product and read the value with a blood glucose meter test strip. If it is a positive result, the blood glucose meter will display the reading; if it is a negative result, the blood glucose meter will display the "LOW" mark.
[0097] The beneficial effects of the present invention are:
[0098] First, the primers disclosed in the present invention are designed based on the unique sequences of the mitochondrial genome of Clonorchis sinensis, and the primers designed on this basis are used for the detection of Clonorchis sinensis for the first time.
[0099] Second, the present invention utilizes the advantages of RPA isothermal amplification, such as convenience, sensitivity, and no need for denaturation and renaturation, combined with the characteristics of CRISPR / Cas12a to specifically identify target genes and trans-cleave ssDNA, and further combines the digital and portable characteristics of blood glucose meters. The combined application of the three can achieve digital quantitative detection of pathogens.
[0100] Third, compared with the existing technology, the present invention is simple, sensitive, and highly specific, and the detection results are digital results readable by the naked eye, which is suitable for epidemic monitoring and screening of clonorchiasis in primary health institutions and veterinary departments.
[0101] Primer combination provided by the present invention and its application for digital detection of Clonorchis sinensis nucleic acid and raw materials and reagents used in the method
[0102] The present invention will be further described below in conjunction with embodiments:
[0103] Example 1 Screening of Clonorchis sinensis-specific target gene sequences
[0104] The mitochondrial genome sequences of six parasites, including Clonorchis sinensis (Accession: MT607652.1), Mesorchis orientalis (Accession: NC028008.1), Opisthorchis civetus (Accession: EU921260.2), Fasciola hepatica (Accession: AF216697.1), Schistosoma japonicum (Accession: KU196417.1), and Antavis anatidae (Accession: MK238506.1), were obtained from Genbank. The sequences were aligned and analyzed using MEGA X software, and the specific sequence of Clonorchis sinensis was selected as the target gene (as shown in Figure 1).
[0105] Primer 5 software was used to design amplification primers, and the primer parameters were set as follows: length, 26-30 bp; GC content, 30%-65%; annealing temperature, 52-58°C.
[0106] The length of the Clonorchis sinensis-specific target gene sequence obtained after screening was 206 bp, and the specific sequence was: 5'-ggataccaccatccattacaagttcctatcctaccctctcaaaacttttctgtccctccgagtatcaaccaacaccaagtcaccttccacataatacccctctcattaacatcctatctaccccgcaatcctacagcctacctgctgcctcttccagcgcctatatattactctccaaccttctttggatctcctctccctctctc-3' (as shown in SEQ ID No. 1).
[0107] The present invention uses the mitochondrial genome of Clonorchis sinensis to compare with the mitochondrial genomes of other trematodes, and designs three pairs of amplification primers, namely:
[0108] Table 1 Primer design for Clonorchis sinensis
[0109]
[0110] The detection effect of three pairs of primers designed based on the target gene region is as follows Fig.10 shown.
[0111] Among them, CSF1 / CSR1 and CSF2 / CSR2 had different degrees of cross-reaction with other types of parasites and poor specificity. The CSmt F / CSmt R primer pair showed high specificity and sensitivity, so this pair of primers was selected for subsequent experiments.
[0112] The sequence of the upstream primer CSmt F is: 5'-ggataccaccatccattacaagttcc-3' (as shown in SEQ ID No. 6), and the sequence of the downstream primer CSmt R is: 5'-gagagagggagaggagatccaaagaagg-3' (as shown in SEQ ID No. 7). The primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd.
[0113] PCR was used to verify the specificity of the primers for CSmt F / CSmt R of Clonorchis sinensis. The amplification reaction system was as follows: 5 ng DNA template, 0.5 μL upstream primer (10 μmol / L), 0.5 μL downstream primer (10 μmol / / L), 12.5 μL PCR reaction solution, add ddH2O to 25 μL, and mix well. The amplification reaction conditions were as follows: pre-denaturation at 94°C for 5 minutes; denaturation at 94°C for 30 seconds, annealing at 56°C for 30 seconds, and extension at 72°C for 20 seconds, for 30 cycles; post-extension at 72°C for 5 minutes.
[0114] Specificity analysis: The genomic DNA of Clonorchis sinensis, Mesorchis orientalis, Fasciola hepatica, Taenia asiatica, Taenia solium, Ancylostoma duodenale, and Cryptosporidium were used as templates, and PCR amplification was performed using the above-mentioned specific primers, and the PCR products were analyzed by agarose gel electrophoresis. The results showed that only the genomic DNA of Clonorchis sinensis could be effectively amplified, proving that the above-mentioned primers have strong specificity (as shown in Figure 2).
[0115] Example 2 Optimization of RPA-CRISPR / Cas12a system
[0116] For gRNA screening of the CRISPR / Cas12a system of Clonorchis sinensis, two gRNAs were designed according to the target gene sequence, gRNA1: 5'-uaauuucuacuaaguguagauuacccaauauauauaugaugugc-3' (as shown in SEQ ID No.8, presented as taatttctactaagtgtagattacccaatatatatgatgtgc in the sequence list), and gRNA2: 5'-uaauuucuacuaaguguagaucacauaauaccccucucauua-3' (as shown in SEQ ID No.9, presented as taatttctactaagtgtagatcacataatacccctctcatta in the sequence list), which were synthesized by Sangon Biotech (Shanghai) Co., Ltd.
[0117] Note: Since u cannot be input when WIPO prepares the sequence table, u is replaced by t in the generated sequence table. However, the correct sequence is still subject to the description in the manual.
[0118] The RPA isothermal amplification technology is used to amplify the gene sequence. Under the guidance of gRNA, Cas12a specifically recognizes the amplified product, activates the trans-cleavage function, and cuts the fluorescent reporter group 5'-FAM-Reporter-BHQ1-3'. The sequence of the fluorescent reporter group is TTAATAA (since the sequence table cannot be generated due to less than 10 nucleotides, it is not numbered here), or cuts the ssDNA single strand on the functional magnetic beads to release sucrase.
[0119] The functional magnetic beads include streptavidin-labeled magnetic beads, ssDNA, and sucrase. Specifically, the ssDNA is: 5'-SH-ssDNA-Biotin-3, and the ssDNA sequence is 5'-tttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttttt-3' (as shown in SEQ ID No. 10).
[0120] RPA reaction system 50μL: including upstream primer (10μM) 2.4μL, downstream primer (10μM) 2.4μL, Buffer 29.5μL, MgOAc (280mM) 2.5μL, 1ng genomic DNA of the sample to be tested, add water to 50μL, and react at 39℃ for 20min.
[0121] The CRISPR / Cas12 fluorescent reaction system is 50 μL: including 5 μL RPA amplification product, 50 nM Cas12a protein, 75 nM gRNA, 100 nM fluorescent reporter group, 5 μL Cas12a Buffer, and dd H2O to 50 μL;
[0122] The CRISPR / Cas12a reaction procedure is: use a multifunctional microplate reader to react for 30 minutes at 37°C, and collect FAM fluorescence intensity every 20 seconds. The results show that both gRNAs can bind to Cas12a and cut the fluorescent reporter group, among which gRNA1 produces a stronger fluorescence intensity and better detection effect (Figure 3).
[0123] The Case12a protein concentration screening of the CRISPR / Cas12a system of Clonorchis sinensis was carried out by referring to the gRNA screening process. After RPA amplification, the Cas12a protein was added into the CRISPR / Cas12a system at 12.5 nM, 25 nM, 50 nM, 75 nM, 100 nM, and 125 nM respectively to detect the fluorescence intensity. The results showed that the fluorescence intensity was the strongest when the Cas12a protein was added at 75 nM, and the effect was the best (Figure 4).
[0124] Screening of gRNA concentration in the CRISPR / Cas12a system of Clonorchis sinensis and screening of Case12a protein concentration in the CRISPR / Cas12a system. After RPA amplification, gRNA1 was added into the CRISPR / Cas12a system at 12.5 nM, 25 nM, 50 nM, 75 nM, 100 nM, 125 nM, and 15 nM to detect fluorescence intensity. The results showed that the fluorescence intensity was the strongest and the effect was the best when the gRNA1 was added at 50 nM (Figure 5).
[0125] Example 3 Detection performance of the RPA-CRISPR / Cas12a system
[0126] Specificity test of CRISPR / Cas12a system for Clonorchis sinensis. 1ng of genomic DNA of Clonorchis sinensis, Mesorchis orientalis, Fasciola hepatica, Taenia asiatica, Taenia solium, Ancylostoma duodenale, and Cryptosporidium was taken as template, and ddH2O was used as negative control. RPA amplification was performed using the above specific primers. The amplified products were used in the CRISPR / Cas12a system to detect the fluorescence intensity. The results showed that only the genomic DNA of Clonorchis sinensis could produce strong fluorescence, proving that the RPA-CRISPR / Cas12a system has strong specificity in detecting Clonorchis sinensis (as shown in Figure 6).
[0127] Sensitivity test of the CRISPR / Cas12a system of Clonorchis sinensis. The plasmid DNA of Clonorchis sinensis was diluted to 10 5 copies / μL, 10 4 copies / μL, 10 3 copies / μL, 10 2 copies / μL, 10 1 copies / μL, 10 0 The above specific primers were used for RPA amplification with 10 copies / μL as template and ddH2O as negative control. The amplified products were used in CRISPR / Cas12a system to detect fluorescence intensity. The results showed that the minimum detection limit of RPA-CRISPR / Cas12a system was 10 1 copies / μL (as shown in Figure 7)
[0128] Example 4 Construction and characterization of functional magnetic beads of RPA-CRISPR / Cas12a-blood glucose meter system
[0129] Construction of functional magnetic beads. Dissolve the 24OD modified ssDNA (5'-SH-ssDNA-Biotin-3) in 200μL ultrapure water and set aside. Take 100μL of purchased streptavidin-labeled magnetic beads (10mg / mL, Sigma) and wash them three times with PBS. Remove the supernatant solution with a magnetic stand each time. Add 200μL of dissolved ssDNA to 100μL of magnetic beads and incubate at room temperature for 2h. After incubation, adsorb the magnetic beads with a magnetic stand and remove the supernatant solution; then add 1μL NaH2PO4 solution (1M) and 1μL 30mM tris(2-carboxyethyl)phosphine (TCEP) aqueous solution, mix well and react at room temperature for 30min to reduce the thiol-modified reporter DNA. Weigh 20 mg of sucrase powder and dissolve it in PBS, add 500 μL of 0.01M 4-(N-maleimidomethyl)cyclohexane-1-carboxylic acid sulfonic acid succinimidyl ester sodium salt aqueous solution (Sulfo-SMCC) coupling agent, mix, vortex thoroughly and react at room temperature for 1 hour. Mix the sucrase solution with magnetic beads-ssDNA and mix in the dark for 48 hours. After incubation, adsorb the magnetic beads with a magnetic stand, remove the supernatant solution, wash three times with PBST, obtain functional magnetic beads, add 100 μL PBS preservation solution, and set aside.
[0130] Characterization of functional magnetic beads. Take 1μL magnetic beads, 1μL ssDNA, 1μL sucrase, and 1μL functional magnetic beads respectively and use NANO full-wavelength UV scanner to detect the peak graph. The results show that the magnetic beads themselves have no peak, ssDNA has an obvious peak at 260nm, sucrase has an obvious peak at 280nm, and functional magnetic beads have an obvious peak at 270nm, indicating that ssDNA and sucrase are coupled to the magnetic beads at the same time, indicating that the functional magnetic beads are successfully prepared (as shown in Figure 8).
[0131] Example 5 Detection performance of the RPA-CRISPR / Cas12a-blood glucose meter system
[0132] Specificity test of RPA-CRISPR / Cas12a-blood glucose meter system for Clonorchis sinensis. 1 ng of genomic DNA of Clonorchis sinensis, Mesorchis orientalis, Fasciola hepatica, Taenia asiatica, Taenia solium, Ancylostoma duodenale, and Cryptosporidium were taken as templates, and ddH2O was used as negative control. RPA amplification was performed using the above-mentioned specific primers. The amplified products were used in the blood glucose meter system: the reaction system of the blood glucose meter was 50 μL: 10 μL of functional magnetic beads, 50 nM of Case12a protein, 75 nM of gRNA, 5 μL of RPA-product, 5 μL of Cas12a Buffer, and dd H2O was added to 50 μL; the reaction was kept at 37°C for 30 min. Use a magnetic stand to separate and remove the functional magnetic beads in step six, take 10 μL of the reaction product and add it to 30 μL of 50 mM sucrose (0.1 M sodium acetate) solution, react at 50 ℃ for 15 min, and take 5 μL of the product to read the value with a blood glucose meter test strip. The results showed that only the genomic DNA of Clonorchis sinensis could produce a reading on the blood glucose meter, and the blood glucose meter test results of other types of parasites were consistent with the negative control results, all of which were "LOW", indicating that the RPA-CRISPR / Cas12a-blood glucose meter system has a strong specificity for detecting Clonorchis sinensis.
[0133] Sensitivity test of the RPA-CRISPR / Cas12a-blood glucose meter system of Clonorchis sinensis. The plasmid DNA of Clonorchis sinensis was diluted to 10 5 copies / μL, 10 4 copies / μL, 10 3 copies / μL, 10 2 copies / μL, 10 1 copies / μL, 10 0 copies / μL was used as template, ddH2O was used as negative control, and the experimental process was carried out according to the "Specificity Test of Clonorchis sinensis RPA-CRISPR / Cas12a-Glucose Meter System". The results showed that the concentration of Clonorchis sinensis plasmid was 10 0 copies / μL, 10 1 When the blood glucose meter displays "LOW" when the concentration of Clonorchis sinensis plasmid is 10 5 copies / μL, 10 4 copies / μL, 10 3 copies / μL, 10 2 copies / μL showed a linear relationship (R 2 =0.989), therefore, the minimum detection limit of the RPA-CRISPR / Cas12a-blood glucose meter system is 10 2copies / μL (as shown in Figure 9).
[0134] Clinical sample detection of Clonorchiasis by RPA-CRISPR / Cas12a-blood glucose meter system. Fecal microscopy is the gold standard for diagnosing Clonorchiasis sinensis, and this can be used as a control to illustrate the accuracy of the present invention. Fecal microscopy and RPA-CRISPR / Cas12a-blood glucose meter were used to detect 49 human fecal samples from Fuyu City, Jilin Province, an endemic area for Clonorchiasis sinensis. The results showed that 26 samples were positive and 23 samples were negative in fecal microscopy, 25 samples were positive and 24 samples were negative in RPA-CRISPR / Cas12a-blood glucose meter, and the sensitivity of the RPA-CRISPR / Cas12a-blood glucose meter system was 96.15%, and the specificity was 95.83%. (As shown in Table 2)
[0135] Table 2 Clinical sample testing
[0136]
[0137] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. A detection composition, characterized in that Includes gRNA, fluorescent reporter and ssDNA, as well as primer combinations; The primer combination consists of the following forward primer and reverse primer composition: The nucleotide sequence of the forward primer is shown in SEQ ID NO.6; the nucleotide sequence of the reverse primer is shown in SEQ ID NO.7; The nucleotide sequence of the gRNA is shown in SEQ ID NO.8 or 9; The nucleotide sequence of the fluorescent reporter group is shown as TTAATAA; The nucleotide sequence of the ssDNA is shown in SEQ ID NO.
10.
2. The detection composition according to claim 1, characterized in that It also includes an RPA reaction system, and one or more of a CRISPR / Cas12 fluorescence reaction system or a blood glucose meter reaction system; The RPA reaction system, in 50 μL, consists of the following components: 2.4 μL of 10 μM upstream primer 2.4 μL of 10 μM downstream primer Buffer 29.5μL 280 mM MgOAc 2.5 μL Genomic DNA of the sample to be tested 1ng Make up to 50 μL with water; The CRISPR / Cas12 fluorescent reaction system is composed of the following components in 50 μL: RPA amplification product 5 μL Cas12a protein 50nM The gRNA 75nM The fluorescent reporter group 100nM Cas12a Buffer 5μL Add dd H2O to make up to 50 μL; The reaction system of the blood glucose meter is 50 μL and consists of the following components: Functional magnetic beads 10 μL Case12a protein 50 nM The gRNA 75nM RPA-product 5μL Cas12a Buffer 5μL Add dd H2O to 50 μL; react at 37°C for 30 min; The functional magnetic beads include magnetic beads labeled with streptavidin, the ssDNA and sucrase.
3. Use of the detection composition as claimed in claim 1 or 2 in the preparation of a reagent for detecting Clonorchis sinensis.
4. Use of the detection composition as claimed in claim 1 or 2 in preparing a kit for detecting Clonorchis sinensis.
5. The use according to claim 3 or 4, characterized in that: The reaction procedure of the CRISPR / Cas12 fluorescent reaction system is as follows: use a multifunctional microplate reader to react at 37° C. for 30 min, and collect the FAM fluorescence intensity once every 20 s.
6. A method for detecting the digitalization of Clonorchis sinensis nucleic acid for non-diagnostic purposes, characterized in that: Based on the detection composition as claimed in claim 1 or 2, taking a sample to be tested, and amplifying it by RPA isothermal amplification technology; The CRISPR / Cas12a system recognizes the target gene and trans-cleaves the fluorescent reporter group 5'-FAM-Reporter-BHQ1-3', or Cutting the ssDNA single strand on the functional magnetic beads to release sucrase, separating the functional magnetic beads to obtain free sucrase, catalyzing the substrate sucrose to generate glucose, measuring the glucose concentration, and obtaining the digital detection result of Clonorchis sinensis nucleic acid; The reaction degree of the RPA isothermal amplification technology is: constant temperature reaction at 39°C for 20 minutes; The reaction procedure of the CRISPR / Cas12 system is as follows: using a multifunctional microplate reader to react at 37°C for 30 minutes, and collecting FAM fluorescence intensity once every 20 seconds; The reaction procedure of the blood glucose meter is: constant temperature reaction at 50°C for 15 min.
7. A reagent or a kit, characterized in that Comprising the detection composition as described in claim 1 or 2.
